glp-1 drugs uses Agonists - What is it? GLP-1 Medications for Weight Loss:

A new GLP-1 medication demonstrated efficacy in reducing blood sugar in people with type 2 diabetes in a phase 2b clinical trial

Given the near-total absence of safety data on these drugs during pregnancy, every prescribing specialist applies the same rule: discontinue at least two months before attempting conception or embryo transfer

They should not be used with DPP-4 inhibitors, in type 1 diabetes, or during pregnancy

Treatment trajectories and switching of drug within the same drug class Between 1 January 2017 and 31 December 2019, 35,105 patients initiated treatment with a GLP-1 receptor agonist (liraglutide: 22,008 [62.7%]

REFERENCES DeFronzo RA

Certain medical conditions and safety concerns make these medications unsafe or not recommended for some people